Literature DB >> 23680810

Avoidable utilization of the chest pain observation unit: evaluation of very-low-risk patients.

Simon A Mahler1, Gregory L Burke, David C Goff, Brian C Hiestand, Bret A Nicks, James W Hoekstra, L Douglas Case, Chadwick D Miller.   

Abstract

BACKGROUND: Very-low-risk patients treated in a chest pain observation unit (CPOU) may threaten efficient care delivery. To optimize the efficiency of CPOU evaluations, it is necessary to quantify the avoidable CPOU utilization rate, examine physician variability, and determine patient and physician characteristics associated with avoidable CPOU utilization.
METHODS: Consecutive chest pain patients were evaluated in an Emergency Department-based CPOU. Patients were risk stratified based on the American College of Cardiology/American Heart Association framework, age, and electrocardiogram findings. Very-low-risk was defined as age <35, physician assessment of low-risk, and normal or nondiagnostic electrocardiogram. Patients identified as very-low-risk were considered avoidable CPOU evaluations. Individual physicians' avoidable CPOU utilization rates were calculated. Patients were followed for 30-day major adverse cardiac events, defined as the composite of death, acute myocardial infarction, and coronary revascularization.
RESULTS: Over 33 months, the registry included 1731 chest pain patients. The study definition of avoidable CPOU evaluations was met by 174 patients (10.1%, 95% confidence interval: 8.7-11.6%). The median rate of physician's avoidable CPOU utilization was 10% (interquartile range: 5.9-13.6%) and varied from 1.9% to 18.4%. None of the patients with an avoidable CPOU evaluation had a major adverse cardiac events within 30 days. Physician predictors of avoidable CPOU utilization included recent residency graduation (<5 years), part-time status, and moderate or high rates of CPOU use.
CONCLUSIONS: Approximately 10% of CPOU evaluations were avoidable. Wide variability exists among physicians regarding their individual rates of avoidable CPOU utilization. This variability could represent an opportunity to improve the efficiency of CPOU care delivery.

Entities:  

Mesh:

Year:  2013        PMID: 23680810      PMCID: PMC5175488          DOI: 10.1097/HPC.0b013e31828dc764

Source DB:  PubMed          Journal:  Crit Pathw Cardiol        ISSN: 1535-2811


  26 in total

1.  Standardized reporting guidelines for studies evaluating risk stratification of emergency department patients with potential acute coronary syndromes.

Authors:  Judd E Hollander; Andra L Blomkalns; Gerard X Brogan; Deborah B Diercks; John M Field; J Lee Garvey; W Brian Gibler; Timothy D Henry; James W Hoekstra; Brian R Holroyd; Yuling Hong; J Douglas Kirk; Brian J O'Neil; Raymond E Jackson; Tom Aufderheide; Andra L Blomkalns; Gerard X Brogan; James Christenson; Sean Collins; Deborah B Diercks; Francis M Fesmire; J Lee Garvey; Gary B Green; Christopher J Lindsell; W Frank Peacock; Charles V Pollack; Robert Zalenski
Journal:  Ann Emerg Med       Date:  2004-12       Impact factor: 5.721

2.  TIMI risk score accurately risk stratifies patients with undifferentiated chest pain presenting to an emergency department.

Authors:  A Conway Morris; D Caesar; S Gray; A Gray
Journal:  Heart       Date:  2006-09       Impact factor: 5.994

3.  Characteristics and outcomes of young adults who present to the emergency department with chest pain.

Authors:  N J Walker; F D Sites; F S Shofer; J E Hollander
Journal:  Acad Emerg Med       Date:  2001-07       Impact factor: 3.451

4.  Application of the TIMI risk score for unstable angina and non-ST elevation acute coronary syndrome to an unselected emergency department chest pain population.

Authors:  Charles V Pollack; Frank D Sites; Frances S Shofer; Keara L Sease; Judd E Hollander
Journal:  Acad Emerg Med       Date:  2005-12-19       Impact factor: 3.451

5.  Symptoms of men and women presenting with acute coronary syndromes.

Authors:  Cynthia Arslanian-Engoren; Amisha Patel; Jianming Fang; David Armstrong; Eva Kline-Rogers; Claire S Duvernoy; Kim A Eagle
Journal:  Am J Cardiol       Date:  2006-09-07       Impact factor: 2.778

6.  Gender disparities in the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: large-scale observations from the CRUSADE (Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes With Early Implementation of the American College of Cardiology/American Heart Association Guidelines) National Quality Improvement Initiative.

Authors:  Andra L Blomkalns; Anita Y Chen; Judith S Hochman; Eric D Peterson; Kelly Trynosky; Deborah B Diercks; Gerard X Brogan; William E Boden; Matthew T Roe; E Magnus Ohman; W Brian Gibler; L Kristin Newby
Journal:  J Am Coll Cardiol       Date:  2005-03-15       Impact factor: 24.094

7.  An emergency department-based protocol for rapidly ruling out myocardial ischemia reduces hospital time and expense: results of a randomized study (ROMIO).

Authors:  M A Gomez; J L Anderson; L A Karagounis; J B Muhlestein; F B Mooers
Journal:  J Am Coll Cardiol       Date:  1996-07       Impact factor: 24.094

8.  Evaluation of a clinical decision rule for young adult patients with chest pain.

Authors:  Robert J Marsan; Kyle J Shaver; Keara L Sease; Frances S Shofer; Frank D Sites; Judd E Hollander
Journal:  Acad Emerg Med       Date:  2005-01       Impact factor: 3.451

9.  Chest pain presenting to the Emergency Department--to stratify risk with GRACE or TIMI?

Authors:  Richard Lyon; Andrew Conway Morris; David Caesar; Sarah Gray; Alasdair Gray
Journal:  Resuscitation       Date:  2007-03-13       Impact factor: 5.262

10.  Pretest probability assessment derived from attribute matching.

Authors:  Jeffrey A Kline; Charles L Johnson; Charles V Pollack; Deborah B Diercks; Judd E Hollander; Craig D Newgard; J Lee Garvey
Journal:  BMC Med Inform Decis Mak       Date:  2005-08-11       Impact factor: 2.796

View more
  1 in total

1.  Observation Units as Substitutes for Hospitalization or Home Discharge.

Authors:  Saul Blecker; Nicholas P Gavin; Hannah Park; Joseph A Ladapo; Stuart D Katz
Journal:  Ann Emerg Med       Date:  2015-11-25       Impact factor: 5.721

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.